Targeting malignant B cells as antigen-presenting cells: TLR-9 agonist induces systemic regression of lymphoma.

Nela Klein-Gonzalez, Udo Holtick, Kirsten Fairfax, Martin R Weihrauch, Michael S von Bergwelt-Baildon

Research output: Contribution to journal › Article › Other

3 Citations (Scopus)

Access to Document

@article{0899ffe8d3c8416c864e29f5309176da,

title = "Targeting malignant B cells as antigen-presenting cells: TLR-9 agonist induces systemic regression of lymphoma.",

author = "Nela Klein-Gonzalez and Udo Holtick and Kirsten Fairfax and Weihrauch, \{Martin R\} and \{von Bergwelt-Baildon\}, \{Michael S\}",

year = "2011",

doi = "10.1586/erv.11.6",

language = "English",

volume = "10",

pages = "295 -- 298",

journal = "Expert Review of Vaccines",

issn = "1476-0584",

publisher = "Taylor \& Francis",

number = "3",

}

TY - JOUR

T1 - Targeting malignant B cells as antigen-presenting cells: TLR-9 agonist induces systemic regression of lymphoma.

AU - Klein-Gonzalez, Nela

AU - Holtick, Udo

AU - Fairfax, Kirsten

AU - Weihrauch, Martin R

AU - von Bergwelt-Baildon, Michael S

PY - 2011

Y1 - 2011

UR - http://www.expert-reviews.com/doi/pdf/10.1586/erv.11.6

U2 - 10.1586/erv.11.6

DO - 10.1586/erv.11.6

M3 - Article

SN - 1476-0584

VL - 10

SP - 295

EP - 298

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

IS - 3

ER -